CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Audience: Of interest to policy-makers. Level: Introductory What you’ll learn: Participants will become familiar with qualitative research principles, common methods used, and when and how qualitative research can be practically used to influence health policy and practice. Andrea Smith, CADTH Brendalynn Ens, CADTH Dr. Deidre DeJean, CADT...
Audience: Of interest to HTA producers. Level: Intermediate What you’ll learn: Knowledge of methods needed to carry out a meta-analysis of diagnostic test accuracy, including the methods needed to correct for imperfect reference standard. Dr. Nandini Dendukuri, McGill University Ian Schiller, McGill University Health Centre‒Research ...
Audience: Of interest to HTA producers. Level: Introductory What you’ll learn: By the end of this workshop, you will understand the role horizon scanning plays in health technology management (HTM), know about sources and processes to identify and prioritize horizon scanning topics, and be able to apply processes to real-world examples. Jef...
Audience: Of interest to HTA producers. Level: Intermediate. What you’ll learn: This is an introduction to survival analysis methods for model-based economic evaluations through practical examples in R. The advantages and disadvantages of each method will be discussed. Dr. Petros Pechlivanoglou, The Hospital for Sick Children (SickKids) N...
Audience: Of interest to HTA producers. Level: Introductory What you’ll learn: Participants will: (i) better understand confounding and confounder summary scores; (ii) be able to estimate propensity scores and disease risk scores; (iii) know their strengths and limits; (iv) have discussed their application within HTA. Dr. Jason Guertin, Uni...
The top three principles for the deliberative process identified by the Health Technology Assessment International 2020 Global Policy Forum were transparency, inclusivity, and impartiality. CADTH has worked with a few patient groups to create a two-part consultation to support wide participation: first, an education session — How CADTH Expert C...
Audience: Of interest to anyone who needs to explain research and complex health topics clearly to people who may not have a research background. Level: Introductory. What you’ll learn: Participants will learn why plain language is necessary and worth the effort, and will discover the steps and skills needed to write well in plain language. He...
CADTH has three expert committees that provide recommendations to publicly funded drug programs, health ministries, and health authorities on the appropriate use of drugs, medical devices, and clinical interventions: CADTH pan-Canadian Oncology Drug Review Expert Review Committee (pERC): cancer drugs CADTH Canadian Drug Expert Committee (CDE...
Audience: Of interest to HTA producers and users, especially those working in child health who produce or consider pediatric health economic evidence. Level: Intermediate What you’ll learn: Participants will gain a deeper understanding of the application of economic evaluation methods to child health. Dr. Wendy Ungar, SickKids Research Inst...
Audience: Of interest to policy-makers. Level: Intermediate. What you’ll learn: This workshop introduces four value of information (VoI) measures and highlights how VoI can determine research priorities that support decision-making. The assumptions of a VoI analysis and methods to display results graphically will also be presented. Dr. Anna...